News

The discontinuance of manufacturing operations is scheduled to take place by the end of March 2010. Taro Ireland plans to continue to maintain the physical plant in good

Opko has acquired Pharmacos Exakta, including a manufacturing facility owned by an affiliate, for cash and shares of Opko Common Stock. Phillip Frost, chairman and CEO of Opko,

HealthLinx said that the study will be run in two stages, stage one of the study is expected to commence late 1st quarter early second quarter this year

Dynavax and GSK said that the selected molecule has moved into advanced preclinical IND-enabling studies that could allow clinical development to begin as early as this year. As

Both the companies are evaluating the complete response letter, in which the FDA has indicated that a preclinical finding of pancreatic acinar cell tumors in rats was of

The funding will be directed towards the first phase of a two year translational programme to take human retinal progenitor cells (hRPCs) towards the clinic in the US,

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Reportedly, Roche has started a 24 weeks Phase 2b study

Both the companies anticipate that this timely re-commitment will reap mutual benefits, as the growing body of AC-11 scientific validation recently has opened several new doors for capitalizing

Gentel Biosciences said that the integrated Proteomics Multi-System includes a high-resolution scanner along with a laptop computer preconfigured with image-capture and analysis software capable of data extraction and